and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.
McKesson (MCK) and Cencora (COR) are positioned to benefit from certain drug price inflation due to contractual provisions. McKesson reported $403.4B revenue and $39.11 EPS for fiscal 2026, with Q1 2027 revenue at $105.4B and EPS at $9.93. Cencora generated $321.3B revenue in fiscal 2025, with Q2 revenue at $78.4B and EPS at $4.75. Both companies have raised EPS forecasts.
How this was made
The 30-second read
Why it matters
Both firms delivered earnings beats and raised guidance, suggesting near‑term upside.
Market read
Earnings beats and guidance lifts for two large‑cap distributors provide a fresh bullish catalyst in a high‑inflation environment.
What to watch
Rising transportation and labor costs may offset inflation‑linked revenue gains.
Background
The article frames rising inflation as an investment theme and highlights two distributors that can profit from drug‑price increases.
Ticker impact
McKesson reported FY2026 revenue of $403.4B (+12%) and raised FY2026 EPS guidance to $44.20‑$45.00 after Q1 2027 results.
Expect price to rally on the earnings beat and guidance lift.
Revenue growth and higher EPS outlook beat expectations, reinforcing bullish sentiment.
Cencora posted Q2 revenue of $78.4B (+3.8%) and lifted FY2025 EPS outlook to $17.65‑$17.90.
Likely upward price movement as investors price in higher earnings.
Both top‑line growth and higher guidance support a bullish outlook.
Market effects
Pharma distribution sector benefits from inflation‑linked contracts, potentially outpacing peers.
U.S. healthcare distribution stocks may see relative strength amid broader inflation concerns.
Large-cap distributors could influence global drug‑price dynamics and related ETFs.
Counterpoint
If drug‑price inflation eases, both companies could see margin compression despite growth.
Key entities
- companyMcKesson
Pharmaceutical distributor with inflation‑linked contracts.
- companyCencora
Pharmaceutical distributor with similar price‑appreciation provisions.
